CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 12 enrolled
Drug / intervention
Triferic AVNUdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04689932
NCT04689932Phase 4Completed
CompareCT.gov

Triferic AVNU Infusion Via Freedom Pump During Hemodialysis

Rockwell Medical Technologies, Inc.·interventional·Posted Dec 30, 2020·Updated Feb 28, 2022

In Brief

A Phase 4 clinical trial evaluating Triferic AVNU for End Stage Renal Disease. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The main purpose of this study is to evaluate the delivery of Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd Stage Renal Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
202120222023202420252026
First PostedDec 30, 2020
Enrollment StartApr 19, 2021
Primary CompletionJun 19, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.5 years ago

Interventions

Triferic AVNUdrug

Ferric Pyrophosphate Citrate